ROIV

Roivant Sciences

38.88

+2.26+6.17%

After Hours: 38.88 0.00 0.00%19:48 11/06 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE36.86/36.62

TODAY RANGE36.62-39.08

VOL12.27M

MARKET CAP28.08B

52 WEEK RANGE19.30-42.50

AVG VOL (3M)7.85M

% TURNOVER1.41%

TURNOVER--

P/E (TTM)-99.8716

% RANGE6.73%

EPS(TTM)-0.3893

P/E(FORWARD)-29.1863

P/B6.64

BVPS5.86

DIVIDEND--

P/S3,380.87

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP21.45B

SHARES OUTSTANDING722.32M

NEXT EARNINGS11/09-11/13

FREE FLOAT551.74M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

NASDAQ·3d ago
Alkermes (ALKS) Surpasses Q3 Earnings and Revenue Estimates
TipRanks·4d ago
Leerink Partners Remains a Buy on Roivant Sciences (ROIV)
NASDAQ·10/29 11:35
Phathom Pharmaceuticals, Inc. (PHAT) Lags Q3 Earnings and Revenue Estimates
Dow Jones·10/28 20:27
Roivant Sciences Price Target Raised to $56.00/Share From $46.00 by Citigroup
Dow Jones·10/28 20:27
Roivant Sciences Is Maintained at Buy by Citigroup
TipRanks·10/28 10:30
Roivant Sciences price target raised to $56 from $46 at Citi
TipRanks·10/22 10:00
Analysts Conflicted on These Healthcare Names: Roivant Sciences (ROIV) and 4D Molecular Therapeutics (FDMT)
TipRanks·10/21 19:35
Roivant Sciences price target raised to $62 from $55 at TD Cowen
TipRanks·10/21 16:40
Analysts Conflicted on These Healthcare Names: Roivant Sciences (ROIV), Alnylam Pharma (ALNY) and Haemonetics (HAE)
TipRanks·10/21 16:16
Midday Fly By: SpaceX reports Q3 beat, will consider Tesla merger
Seeking Alpha·10/21 13:23
Roivant to seek label expansion for Lisraya in uveitis after late-stage trial win
Dow Jones·10/21 11:54
Roivant Shares Gain on Positive Study Results for Non-Infectious Uveitis Treatment
TipRanks·10/21 11:31
Roivant, Priovant report CLARITY-1 and CLARITY-2 trials meet primary endpoint
TipRanks·10/21 11:29
Roivant reports strong Phase 3 data in uveitis
TipRanks·10/13 17:20
Chardan biotech/pharma analysts hold analyst/industry conference call

Same Industry

Name/Symbol

Change%

Price

ROIV

MCK

BIIB

AMGN

SHPG

CELG-RT

LLY

CELG

TXMD

JNJ

ABBV

ZTS

GILD

Novo-Nordisk A/S

NVO

+0.02%

40.31

BMY

PFE

ALXN

SNY

GCVRZ

NVS

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.